Articles Posted in 2013

  • Pravachol Linked to Memory Impairment

    New research that looked at whether two commonly prescribed statin medicines, used to lower low-density lipoprotein (LDL) or ‘bad cholesterol’ levels in the blood, can adversely affect cognitive function has found that one of the drugs tested caused memory impairment in rats. Between six and seven million people in the UK take statins daily and […]

  • Exclusive: U.S. prosecutors add China bribe allegations to GSK probe

      U.S. authorities are investigating British drugmaker GlaxoSmithKline Plc for violations of U.S. anti-bribery laws in China after Chinese government officials accused the company of bribing doctors, three sources familiar with the probe said this week. Once again, GlaxoSmithKline has the U.S. Justice Department on its tail. Prosecutors are investigating bribery allegations that Glaxo ($GSK) […]

  • Merck vaccine developer admits vaccines routinely contain hidden cancer viruses derived from diseased monkeys

    If you haven’t yet realized the truth about how vaccines contain hidden cancer viruses, prepare yourself to be shocked by the admission you’re about to hear. Decades ago, one of the most prominent vaccine scientists in the history of the vaccine industry — a Merck scientist — made a recording where he openly admitted that […]

  • FDA probes long-acting Zyprexa safety after 2 patients die

    Two patients have died unexpectedly after their Zyprexa Relprevv injections, and the FDA is now investigating. The agency says the patients died three to four days after receiving “an appropriate dose,” and both had “very high” blood levels of olanzapine, the long-acting Zyprexa product’s active ingredient. Under a risk-management plan imposed when Zyprexa Relprevv was […]

  • Vegetarian Diets Associated With Lower Risk of Death

    June 3, 2013 — Vegetarian diets are associated with reduced death rates in a study of more than 70,000 Seventh-day Adventists with more favorable results for men than women, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication. The possible relationship between diet and mortality is an important area […]

  • Ranbaxy inks record-setting $500M manufacturing settlement

      Ranbaxy Laboratories made history . The India-based generics maker pleaded guilty to U.S. drug safety violations and agreed to pay $500 million in penalties, in the largest-ever federal settlement with a maker of copycat drugs. Ranbaxy pleaded guilty to three felony counts of violating drug-safety laws and four felony counts of making false statements […]

  • U.S. Sues Novartis Again, Accusing It of Kickbacks

    The United States government  announced its second civil fraud lawsuit against the Swiss drug maker Novartis in four days, accusing a unit of the company of paying multimillion-dollar kickbacks to doctors in exchange for prescribing its drugs. The authorities said that for a decade, the company lavished healthy speaking fees and “opulent” meals, including a […]

  • Air Pollution Linked To Heart Disease Through Increased Hardening Of The Arteries

    Long term exposure to air pollution may be linked to heart attacks and strokes by speeding up atherosclerosis, or “hardening of the arteries”, according to a study by U.S. researchers published in  PLOS Medicine. The researchers, led by Sara Adar, John Searle Assistant Professor of Epidemiology, University of Michigan School of Public Health, and Joel […]

  • 40% Of Parents Give Young Children Drugs They Shouldn’t

    Forty percent of parents give children under the age of 4 cough medications they should not receive.Despite doctors’ advice, many parents still turn to OTC (over-the-counter) cough medicines for their very young kids. It is not surprising that parents get medications for their young children, especially as most of them catch colds from five to […]

  • Common Osteoporosis Drug Slows Formation of New Bone

    Osteoporosis weakens bones and increases the risk that patients will suffer fractures. Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM). “The key […]